Skip to main content

Postmenopausal Osteoporosis

Tracking # 20-680799

$6.95

5 (1 ratings)
Learn more
CE Broker Reporting Reported automatically
Method Home Study

Course overview

RX/NP Objectives 1.Describe the pathophysiology, risk factors, and screening methods for osteoporosis. 2.Discuss guideline recommendations for osteoporosis prevention and treatment. Compare bisphosphonates, denosumab, parathyroid hormone analogs, romosozumab, raloxifene, and estrogen in terms of effectiveness and adverse effect concerns. 3.Counsel patients regarding the importance of calcium and vitamin D intake and the dosing options/appropriate administration of medications used for the treatment and prevention of osteoporosis. Tech Objectives 1.Name five drug classes that are indicated for the prevention and/or treatment of osteoporosis; recognize the brand and generic name(s) for the medication(s) in each class. 2.For each medication used to prevent or treat osteoporosis, describe the recommended usual dose and how it should be administered. 3.List the common side effects, safety concerns, and contraindications for medications used for the treatment of osteoporosis.

Subject areas

This course counts toward the state boards and subject areas below.

Arkansas State Board of Nursing

Registered Nurse

1.5h Practice-Focused Continuing Education

District of Columbia Board of Nursing

Registered Nurse

1.5h Registered Nurse District of Columbia - Continuing Education

Florida Board of Nursing

Advanced Practice Registered Nurse

1.5h General

Licensed Practical Nurse

1.5h General

Registered Nurse

1.5h General

Georgia Board of Nursing

Licensed Practical Nurse

1.5h General

Registered Professional Nurse

1.5h General

New Mexico Board of Nursing

Certified Nurse Practitioner

1.5h Continuing education related to pharmacology

Certified Registered Nurse Anesthetist

1.5h Continuing education related to pharmacology

Clinical Nurse Specialist

1.5h Continuing education related to pharmacology

South Carolina Board of Nursing

Advanced Practice Registered Nurse

1.5h General

Licensed Practical Nurse

1.5h General

Registered Nurse

1.5h General

Disclosure statements

Christina Polomoff, Pharm.D, BCACP, BCGP and Marissa Salvo, PharmD, BCACP reports no financial relationship with the manufacturer(s) or provider(s) of any commercial product(s) or service(s) that appear in this issue.

Learner Feedback